Back
Day Range
$35.00
$35.97
52-Week Range
$21.00
$37.25
Volume
145
50D / 200D Avg
$36.67
/
$33.88
Prev Close
$35.97
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 123.8 | 0.4 |
| P/B | 5.0 | 2.9 |
| ROE % | 3.8 | 3.8 |
| Net Margin % | 2.9 | 3.9 |
| Rev Growth 5Y % | 4.0 | 10.0 |
| D/E | 0.6 | 0.2 |
Key Takeaways
Revenue grew 4.04% annually over 5 years — modest growth
Earnings grew 144.30% over the past year
ROE of 3.77% is below average
Generating 48.60M in free cash flow
P/E of 123.76 — premium valuation
PEG of 0.60 suggests growth is underpriced
Growth
Revenue Growth (5Y)
4.04%
Revenue (1Y)0.60%
Earnings (1Y)144.30%
FCF Growth (3Y)78.81%
Quality
Return on Equity
3.77%
ROIC4.29%
Net Margin2.87%
Op. Margin6.30%
Safety
Debt / Equity
0.56
Current Ratio1.94
Interest Coverage2.07
Valuation
P/E Ratio
123.76
P/B Ratio5.02
EV/EBITDA61.47
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.60% | Revenue Growth (3Y) | -1.23% |
| Earnings Growth (1Y) | 144.30% | Earnings Growth (3Y) | -23.87% |
| Revenue Growth (5Y) | 4.04% | Earnings Growth (5Y) | -20.08% |
| Profitability | |||
| Revenue (TTM) | 672.80M | Net Income (TTM) | 19.30M |
| ROE | 3.77% | ROA | 2.15% |
| Gross Margin | 100.00% | Operating Margin | 6.30% |
| Net Margin | 2.87% | Free Cash Flow (TTM) | 48.60M |
| ROIC | 4.29% | FCF Growth (3Y) | 78.81% |
| Safety | |||
| Debt / Equity | 0.56 | Current Ratio | 1.94 |
| Interest Coverage | 2.07 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 123.76 | P/B Ratio | 5.02 |
| P/S Ratio | 3.55 | PEG Ratio | 0.60 |
| EV/EBITDA | 61.47 | Dividend Yield | 0.02% |
| Market Cap | 2.39B | Enterprise Value | 2.61B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 672.80M | 668.80M | 689.70M | 593.40M | 574.30M |
| Net Income | 19.30M | 7.90M | 33.30M | 40.90M | 47.30M |
| EPS (Diluted) | 0.25 | 0.12 | 0.50 | 0.62 | 0.72 |
| Gross Profit | 672.80M | 178.70M | 239.30M | 226.00M | 232.20M |
| Operating Income | 42.40M | 6.40M | 40.50M | 56.60M | 61.50M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 899.00M | 1.03B | 1.01B | 1.02B | 851.00M |
| Total Liabilities | 423.00M | 485.00M | 440.30M | 445.80M | 354.40M |
| Shareholders' Equity | 475.60M | 548.20M | 569.40M | 578.50M | 498.10M |
| Total Debt | 265.90M | 291.20M | 232.10M | 223.80M | 151.60M |
| Cash & Equivalents | 48.00M | 42.50M | 36.30M | 38.80M | 46.00M |
| Current Assets | 254.40M | 271.10M | 259.00M | 257.50M | 231.70M |
| Current Liabilities | 131.30M | 150.60M | 147.20M | 151.30M | 142.50M |